December 4, 2022

Medical Trend

Medical News and Medical Resources

Why does Japan stop the HPV vaccination for women?

Why does Japan stop the HPV vaccination for women?



 

Why does Japan stop the HPV vaccination for women?

 

The so-called HPV vaccine is also known by many as the cervical cancer vaccine.

The reason why the two are related is because cervical cancer is the only gynecological malignant tumor with a clear etiology so far.

 

It is related to the persistent infection of high-risk types of HPV in women, especially HPV types 16 and 18 are closely related to cervical cancer . The injection of HPV vaccine means avoiding the risk of viral infection, which in turn reduces the risk of cervical cancer in women in the future.

 

Why does Japan stop the HPV vaccination for women?

 

 

In fact, many people in life have doubts about this vaccine, especially after some people learned from the Internet that Japan, which is a medically developed country, will stop the HPV vaccine for women, it is even more panic. They were afraid of the ineffectiveness of HPV vaccination and the side effects on the body, so they refused the vaccine.

 

So the question is, why Japan, with developed medical care and very open sexual attitudes, should stop the HPV vaccine for women?

 

In fact, the biggest reason why Japan wants to stop HPV vaccination is that Japanese women do not trust this vaccine.

You know, Japan’s medical care is very complete, and medical technology is relatively advanced. As early as 2010, the Japanese government has implemented a free HPV vaccination program, as long as women over the age of 12 can be vaccinated locally for free.

 

However, with the spread of vaccines, many problems have also been exposed.

Some women experience adverse reactions after receiving the HPV vaccine, such as pain at the vaccination site, body pain, and difficulty standing .

 

The local media immediately seized on these ills and began to hype them up. This has led to the exposure of many victims, and the bad media are adding fuel to it.

This caused the Japanese people to protest and refuse to receive the HPV vaccine.

 

In fact, after receiving the HPV vaccine, a small number of women did experience similar problems, with an average of about 15.6 similar reactions per 100,000 people .

 

However, after a one-year follow-up and follow-up survey in Japan, women who have been vaccinated with the vaccine have a much lower incidence rate than those who have not been vaccinated, and the incidence of adverse reactions is also very low.

At the same time, there is no direct evidence to confirm that adverse reactions will definitely occur after HPV vaccination.

 

However, due to the pressure of public opinion, Japan finally suspended the active recommendation of HPV vaccination, but the suspension of recommended vaccination was not a complete suspension of vaccination, but changed to voluntary vaccination of women.

Therefore, this vaccine is not as terrible as everyone imagines, it is an effective vaccine to prevent HPV virus infection, and it is helpful to prevent cervical cancer.

 

So far, there are three main types of HPV vaccines in some countries, namely bivalent, quadrivalent and nine-valent vaccines.

These three correspond to different HPV subtypes and are suitable for different ages. However, the preventive effects of these three vaccines cannot be questioned, reaching more than 99% .

Therefore, it is recommended that everyone get vaccinated under the conditions.

 

It should be emphasized here that no vaccine can guarantee itself to be 100% effective. Moreover, the causes of cancer are quite complicated, and the vaccine only prevents viral infection.

 

Therefore, even if vaccinated, for high-risk women with a history of multiple miscarriages, multiple births, long-term smoking and drinking, premature marriage and sexual behavior, annual cervical cancer screening is required to avoid the occurrence of Cancer without knowing it.

 

 

 

 

Why does Japan stop the HPV vaccination for women?

(source:internet, reference only)


Disclaimer of medicaltrend.org